BNIP3L/BNIP3‐Mediated Mitophagy Contributes to the Maintenance of Ovarian Cancer Stem Cells
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70704 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Na Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Mitophagy, Ovarian Neoplasms, Neoplastic Stem Cells, Membrane Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Ovarian cancer remains the most lethal gynaecological malignancy, with tumour recurrence and chemoresistance posing significant therapeutic challenges. Emerging evidence suggests that cancer stem cells (CSCs), a rare subpopulation within tumours with self‐renewal and differentiation capacities, contribute to these hurdles. Therefore, elucidating the mechanisms that sustain CSCs is critical for improving treatment strategies. Mitophagy, a selective process for eliminating damaged mitochondria, plays a key role in maintaining cellular homeostasis, including CSC survival. Our study demonstrates that ovarian CSCs exhibit enhanced mitophagy, accompanied by elevated expression of the mitochondrial outer membrane receptors BNIP3 and BNIP3L. Knockdown of BNIP3 or BNIP3L significantly reduces mitophagy and impairs CSC self‐renewal, indicating that receptor‐mediated mitophagy is essential for CSC maintenance. Mechanistically, we identify that hyperactivated NF‐κB signalling drives the upregulation of BNIP3 and BNIP3L in ovarian CSCs. Inhibition of NF‐κB signalling, either via p65 knockdown or pharmacological inhibitors, effectively suppresses mitophagy. Furthermore, we demonstrate that elevated DNA‐PK expression contributes to the constitutive activation of NF‐κB signalling, thereby promoting mitophagy in ovarian CSCs. In summary, our findings establish that BNIP3/BNIP3L‐mediated mitophagy, driven by DNA‐PK‐dependent NF‐κB hyperactivation, is essential for CSC maintenance. Targeting the DNA‐PK/NF‐κB/BNIP3L‐BNIP3 axis to disrupt mitochondrial quality control in CSCs represents a promising therapeutic strategy to prevent ovarian cancer recurrence and metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.
- Department of Pathology, College of Medicine, The Ohio State University, Columbus, Ohio, USA.
- Department of Obstetrics and Gynecology, College of Medicine, The Ohio State University, Columbus, Ohio, USA.
- Department of Chemistry and Biochemistry, College of Biology, The Ohio State University, Columbus, Ohio, USA.
ORCID-Profile: Qi-En Wang
Förderung
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Li, N., Pal Khaket, T., Yang, Y., Wang, L., Cai, S., Li, A., Wani, E., Miao, J., Zhang, N., Zheng, Q., Zhang, J., Liu, X., Karuppaiyah, S., Pei, D., & Wang, Q. E. (2025). BNIP3L/BNIP3‐Mediated Mitophagy Contributes to the Maintenance of Ovarian Cancer Stem Cells. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70704
Vancouver
Li N, Pal Khaket T, Yang Y, Wang L, Cai S, Li A, et al. BNIP3L/BNIP3‐Mediated Mitophagy Contributes to the Maintenance of Ovarian Cancer Stem Cells. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70704
BibTeX
@article{Li2025,
author = {Li, Na and Pal Khaket, Tejinder and Yang, Yajing and Wang, Linzhou and Cai, Shurui and Li, Aidan and Wani, Elsa and Miao, Jessica and Zhang, Nan and Zheng, Qingfei and Zhang, Junran and Liu, Xuefeng and Karuppaiyah, Selvendiran and Pei, Dehua and Wang, Qi-En},
title = {BNIP3L/BNIP3‐Mediated Mitophagy Contributes to the Maintenance of Ovarian Cancer Stem Cells},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70704}
}
EUVIMED